Patient Satisfaction in Stroke Patients

Completed

• Conditions: Stroke

• Registration Number: NCT00994409
• Lead Sponsor: Charite University, Berlin, Germany

Brief Summary

The objective of this trial is to guarantee a follow-up of all stroke and transient ischemic attack (TIA) patients. With this follow-up assessment long term effects of therapy and prevention measures can be detected and monitored. It is part of quality assurance.

Detailed Description

Primary efficacy endpoint: Number of patients who state that they received all the information they want about the causes and nature of their illness Key secondary endpoint(s): Compliance/adherence with discharge medication. Re-events. Degree of Disability. Activities of daily living. Mortality.

Study Timeline

• Study Start: 2008-07
• Study First Submitted: 2009-10-13
• Study First Submitted QC: 2009-10-13
• Study First Posted: 2009-10-14
• Primary Completion: 2010-07
• Status Verified: 2010-11
• Study Completion: 2010-11
• Last Update Submitted: 2010-11-30
• Last Update Posted: 2010-12-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1200

Inclusion Criteria

• all patients eligible

Exclusion Criteria

• none

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary efficacy endpoint: Number of patients who state that they received all the information they want about the causes and nature of their illness.	September 2010

Secondary Outcome Measures

Name	Time	Method
Compliance/adherence with discharge medication Activities of daily living	September 2010
Re-events	September 2010
Degree of Disability	September 2010
Mortality	September 2010

Trial Locations

Locations (1)

Dept. Neurology, Charité Campus Benjamin Franklin; 🇩🇪 Berlin, Germany